Associated Medical Conditions for Systemic Lupus Erythematosus

The following is based on bacteria published studies. These are report on the averages of a group of patients; they do not apply to all patients and are not necessary predictive.

For some medical conditions there are hundreds of bacteria shifts reported, for others only a few. The Percentage is based on the least number. If there are matches 8 matches for a condition that has 10 known bacteria shifts, against a condition that has 50 bacteria shifts. It will be 8/10 or 80% and not 8/50= 16%. The count of possible bacteria is shown for reference.

Associations

Limited to conditions with 5 or more bacteria

Name Percent Est Matches Bacteria in From Bacteria in To
Allergies 18 % 9 50 66
Alzheimer's disease 28 % 14 50 66
Autism 31.8 % 21 110 66
Ulcerative colitis 37.9 % 25 108 66
Rosacea 18.2 % 4 22 66
Schizophrenia 33.3 % 22 93 66
Ankylosing spondylitis 42.4 % 28 520 66
Mood Disorders 50 % 3 6 66
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 34.8 % 23 134 66
Psoriasis 21.7 % 10 46 66
Multiple Sclerosis 27.3 % 18 100 66
Obesity 28.8 % 19 104 66
Osteoporosis 45.5 % 10 22 66
Amyotrophic lateral sclerosis (ALS) Motor Neuron 20.9 % 9 43 66
neuropsychiatric disorders (PANDAS, PANS) 33.3 % 5 15 66
ME/CFS without IBS 23.1 % 6 26 66
Obesity 20 % 11 55 66
Metabolic Syndrome 14.3 % 1 7 66
ME/CFS with IBS 21.1 % 4 19 66
Liver Cirrhosis 43.9 % 29 678 66
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 28.8 % 19 76 66
Parkinson's Disease 34.8 % 23 90 66
Insomnia 50 % 5 10 66
Chronic Kidney Disease 42.9 % 15 35 66
Depression 37.9 % 25 81 66
Irritable Bowel Syndrome 22.6 % 14 62 66
IgA nephropathy (IgAN) 17.2 % 5 29 66
Chronic Urticaria (Hives) 39.1 % 9 23 66
Hyperlipidemia (High Blood Fats) 24 % 6 25 66
hypercholesterolemia (High Cholesterol) 11.1 % 1 9 66
Allergic Rhinitis (Hay Fever) 25 % 9 36 66
gallstone disease (gsd) 26.7 % 4 15 66
Graves' disease 37.5 % 3 8 66
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 20.8 % 5 24 66
Fibromyalgia 13.5 % 5 37 66
Functional constipation / chronic idiopathic constipation 24.4 % 10 41 66
Gout 23.8 % 5 21 66
Epilepsy 28 % 7 25 66
Cerebral Palsy 47.1 % 8 17 66
Inflammatory Bowel Disease 30.3 % 20 66 66
Type 1 Diabetes 28.8 % 15 52 66
COVID-19 27.8 % 10 36 66
Carcinoma 25.5 % 13 51 66
Colorectal Cancer 24.2 % 16 296 66
Celiac Disease 21.2 % 14 67 66
Chronic Fatigue Syndrome 18.2 % 10 55 66
Crohn's Disease 47 % 31 141 66
Coronary artery disease 18.8 % 3 16 66
Barrett esophagus cancer 12.5 % 2 16 66
Bipolar Disorder 36.4 % 12 33 66
Asthma 33.3 % 9 27 66
Atherosclerosis 34.8 % 23 524 66
Acne 52.6 % 10 19 66
Small Intestinal Bacterial Overgrowth (SIBO) 31.3 % 5 16 66
Generalized anxiety disorder 35.7 % 5 14 66
Brain Trauma 27.3 % 6 22 66
Sjögren syndrome 39 % 16 41 66
Type 2 Diabetes 56.1 % 37 267 66
Stress / posttraumatic stress disorder 33.9 % 19 56 66
ADHD 29.8 % 14 47 66
Hashimoto's thyroiditis 28.6 % 4 14 66

(Legacy User)

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2021 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 ยงโ€ฏ1030, CETS No.185, CFAA